Identification of ACE-inhibitory peptides in salt-free soy sauce that are transportable across caco-2 cell monolayers

Peptides

Volumn 29, Issue 3, 2008, Pages 338-344

  Zhu, Xiao Lin ^a   Watanabe, Keisuke ^a   Shiraishi, Koso ^b   Ueki, Tatsuro ^c   Noda, Yoshiharu ^c   Matsui, Toshiro ^a   Matsumoto, Kiyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b EZAKI GLICO CO LTD   (Japan)

^c Fukuoka Soy Sauce Brewing Co   (Japan)

Author keywords

Absorption; Angiotensin I converting enzyme; Caco 2; Peptide; Salt free soy sauce

Indexed keywords

ALANYLPHENYLALANINE; DIPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOLEUCYLPHENYLALANINE; PHENYLALANYLISOLEUCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ASPERGILLUS ORYZAE; CELL STRAIN CACO 2; CONTROLLED STUDY; FERMENTATION; HUMAN; HUMAN CELL; IC 50; KINETICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; SOYBEAN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; KINETICS; PEPTIDES; SALTS; SOY FOODS;

ASPERGILLUS ORYZAE; GLYCINE MAX; SANDFLY FEVER SICILIAN VIRUS;

EID: 39649089143     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.11.006     Document Type: Article

References (31)

1. Anand B.S., Patel J., and Mitra A.K. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-caco-2. J Pharmacol Exp Ther 304 (2003) 781-791
2. Ariyoshi Y. Angiotensin converting enzyme inhibitors derived from food proteins. Trends Food Sci Technol 4 (1993) 139-144
3. Bailey P.D., Boyd C.A., Bronk J.R., Collier I.D., Meredith D., Morgan K.M., et al. How to make drugs orally active: a substrate template for peptide transporter PepT1. Angew Chem Int Ed Engl 39 (2000) 505-508
4. Behrens I., and Kissek T. Do cell culture conditions influence the carrier-mediated transport of peptides in caco-2 cell monolayers?. Eur J Pharm Sci 19 (2003) 433-442
5. Briske-Anderson M.J., Finley J.W., and Newman S.M. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med 214 (1997) 248-257
6. Cheng Y.Y., Anne H.D., and Charles P. Intestinal peptide transport systems and oral drug availability. Pharm Res 16 (1999) 1331-1343
7. Chobanian A.V., and Hill M. National Heart Lung and Blood Institute Workshop on sodium and blood pressure: a critical review of current scientific evidence. Hypertension 35 (2000) 858-863
8. Clare D.A., and Swaisgood H.E. Bioactive milk peptides: a prospectus. J Dairy Sci 83 (2000) 1187-1195
9. Health and Nutrition Information Study group. Annual report of the National Nutrition Survey in 1999 (2001), Daiichi Publishing Co., Tokyo p. 39-40 (in Japanese)
10. Kinoshita E., Yamakoshi J., and Kikuchi M. Purification and identification of an angiotensin I-converting enzyme inhibitor from soy sauce. Biosci Biotechnol Biochem 57 (1993) 1107-1110
11. Kuboda K, Noda Y. Japanese Patent 2964370 1999.
12. Lin C.J., Akarawut W., and Smith D.E. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicle. Pharm Res 16 (1999) 609-615
13. Matsui T., Imamura M., Oka H., Osajima K., Kimoto K., Kawasaki T., et al. Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. J Pept Sci 10 (2004) 535-545
14. Matsui T., and Matsumoto K. Antihypertensive peptide from nature resources. In: Khan M.T.H., and Ather A. (Eds). Lead molecules from natural products: discovery and trends (2006), Elsevier B.V., The Netherlands 259-276 (Chapter 15)
15. Matsui T., Tamaya K., Seki E., Osajima K., Matsumoto K., and Kawasaki T. Val-Tyr as a natural antihypertensive dipeptide can be absorbed into human circulatory blood system. Clin Exp Pharmacol Physiol 29 (2002) 204-208
16. Matsui T., Zhu X.L., Watanabe K., Tanaka K., Kusano Y., and Matsumoto K. Combined administration of captopril with an antihypertensive Val-Tyr di-peptide to spontaneously hypertensive rats attenuates the blood pressure lowering effect. Life Sci 79 (2006) 2492-2498
17. Matsui T., Yukiyoshi A., Doi S., Sugimoto H., Yamada H., and Matsumoto K. Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J Nutr Biochem 13 (2002) 80-86
18. Menon R.M., and Barr W.H. Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chamber. Biopharm Drug Disp 24 (2003) 299-308
19. Meredith D., Temple C.S., Guha N., Sword C.J., Boyd C.A.R., Collier I.D., et al. Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1. Eur J Biochem 267 (2000) 3723-3728
20. Satake M., Enjoh M., Nakamura Y., Takano T., Kawamura Y., Arai S., et al. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 66 (2002) 378-384
21. Shin Z.I., Yu R., Park S.A., Chung D.K., Ahn C.W., Nam H.S., et al. An angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo. J Agric Food Chem 49 (2001) 3004-3009
22. Schlimme E., and Meisel H. Bioactive peptides derived from milk protein. Structural, physiological and analytical aspects. Die Nahrung 39 (1995) 1-20
23. Scientific Advisory Committee on Nutrition: Salt and Health. SACN/SaltSub/03/02 2003, p. 1-34.
24. Siamak A.A., and Emile L.M. Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption. J Clin Invest 50 (1971) 2266-2275
25. Siamak A.A., and Mohammad R.S. Functional characterization of dipeptide transport system in human jejunum. J Clin Invest 53 (1974) 1368-1374
26. Steijns J. Dietary proteins as the source of new health promoting bio-active peptides with special attention to glutamine peptide. Food Technol Eur (1996; March/April) 80-84
27. Tsuda M., Terada T., Irie M., Katsura T., Niida A., Tomita K., et al. Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther 318 (2006) 455-460
28. Watanabe H., Kashimoto N., Kajimura J., and Kamiya K. A miso (Japanese soybean paste) diet conferred greater protection against hypertension than a sodium chloride diet in Dahl salt-sensitive rats. Hypertens Res 29 (2006) 731-738
29. Wu J.P., and Ding X.L. Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides. Food Res Int 35 (2002) 367-375
30. Wu J.P., and Ding X.L. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem 49 (2001) 501-506
31. Zhu T., Chen X.Z., Steel A., Hdiger M.A., and Smith D.E. Differential recognition of ACE inhibitors in Xenopus lavevis oocytes expressing rat PEPT1 and PEPT2. Pharm Res 17 (2000) 526-532